Ischemic Stroke Market Outlook 2023: Trends, Future Prospects and CAGR of 8.3% Along with Top Key Players

Ischemic Stroke Market research report by Market Research Future delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period 2019-2023

Pune, Maharashtra - May 15, 2019 /MarketersMedia/ —

Ischemic Strokes occur when an artery or blood vessel supplying blood to the brain is blocked. The brain is dependent on the arteries to bring fresh blood from the lungs and heart. A blockage in the same causes ischemic stroke. The underlying reason behind such obstruction is the development of fatty deposits lining the vessel walls, also known as atherosclerosis.

The evolving lifestyle of individuals, prevalence of diabetes, increasing ageing population, and high tobacco usage are the major factors driving the market. Additionally, the increasing demand for minimally invasive procedures and advancements in surgical procedures are some of the key factors accelerating the growth of the global market. However, the high cost associated with such surgical procedures and the excessive medicinal usage for the treatment of the condition is reported as a major hindrance to the market growth.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/5423

Ischemic Stroke Market - Key Players

Some of key the players in the Ischemic Stroke Market are

Abbott Laboratories (U.S.)
Medtronic plc (U.S.)
Boston Scientific Corporation (U.S.)
Cordis Corporation (U.S.)
Koninklijke Philips N.V. (Netherland)
GE Healthcare (U.S.)
Stryker Corporation (U.S.)
Genentech, Inc. (U.S.)
Merck & Co., Inc. (U.S.)
Bayer AG (Germany)
Boehringer Ingelheim (Germany)
Sanofi (France)
Covidien plc (Ireland)
Philips Healthcare (U.S.)
Johnson & Johnson (U.S.)
Penumbra, Inc. (U.S.)
GE Healthcare (U.S.)
Siemens Healthcare (U.S.)
Hitachi, Ltd (Japan)
Biogen (U.S.)
Daiichi Sankyo (U.S.)
Pfizer Inc. (U.S.)

Ischemic Stroke Market - Segmentation

The Ischemic Stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.

On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.

On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/5423

On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy

On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.

Ischemic Stroke Market - Regional Analysis

The Global Ischemic Stroke Market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.

The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.

Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe

Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.

The Middle East region Ischemic Stroke Market is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423

Source URL: https://marketersmedia.com/ischemic-stroke-market-outlook-2023-trends-future-prospects-and-cagr-of-83-along-with-top-key-players/512807

Source: MarketersMedia

Release ID: 512807